Current approaches to testing new treatments for multidrug resistant bacterial diseases raise scientific and ethical issues for current and future patients, say John Powers and colleagues Click to show full abstract
Current approaches to testing new treatments for multidrug resistant bacterial diseases raise scientific and ethical issues for current and future patients, say John Powers and colleagues
               
Click one of the above tabs to view related content.